<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02873793</url>
  </required_header>
  <id_info>
    <org_study_id>FAUQUE 2014</org_study_id>
    <nct_id>NCT02873793</nct_id>
  </id_info>
  <brief_title>Analysis of Transposon Control Pathways in Germinal Cancers of the Testicle</brief_title>
  <acronym>SEMINOMES</acronym>
  <official_title>Analysis of Transposon Control Pathways in Germinal Cancers of the Testicle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      By analogy with the mouse, the activity of control pathways for transposable elements (TE) in
      foetal primordial germinal cells could prove to be a determinant for fertility in adulthood
      in humans. Moreover, defects in the control of transposable elements (TE) could also
      contribute to the aetiology of germinal testicular cancer, by inducing chromosomal
      instability and tumorigenesis. In this context, the aim is to analyse a specific type of
      adult germinal testicular cancers, seminomas. Directly related to our research interest, the
      histological, transcriptomic and epigenetic features of theses adult tumours are reminiscent
      of germinal cells normally present in foetuses. The investigator postulates that these
      similarities could also extend to the biology of transposable elements (TE), and in
      particular to the initiation of the control of these elements. The management of seminomas
      requires surgery, orchiectomy, which consists of the total excision of the affected
      testicles. Using high-resolution high-throughput sequencing techniques, we propose to analyse
      the control pathways of transposable elements (TE) in tumour samples harvested from surgical
      pieces in comparison with adjacent healthy tissue. The results obtained in these tumour
      samples will be compared with those in normal foetal gonad samples.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The role of Transposable Element in tumorigenesis seminomas adults</measure>
    <time_frame>through the study completion up to 36 months</time_frame>
    <description>Transcriptomic analysis of adult seminomas</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Germinal Cancers of the Testicle</condition>
  <arm_group>
    <arm_group_label>7/8 cases pure seminomas</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>5 cases of non-seminoma</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>3 cases of composite tumours seminoma/non-seminoma.</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Extraction of total RNA from healthy and tumour tissues</intervention_name>
    <arm_group_label>7/8 cases pure seminomas</arm_group_label>
    <arm_group_label>5 cases of non-seminoma</arm_group_label>
    <arm_group_label>3 cases of composite tumours seminoma/non-seminoma.</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Extraction of total RNA from healthy and tumour tissues
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        men with germinal testicular cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men who have provided oral consent

          -  men with germinal testicular cancer with negative or low serum markers (Alpha Foeto
             Protein AFP and Human Chorionic Gonadotrophin hCG), indicators of a seminomatous-type
             tumour

          -  men who have undergone orchiectomy (total excision of the affected testicle)

          -  confirmation of the diagnosis of seminomatous or non-seminomatous type by histology of
             the surgical piece

          -  absence of hepatitis B or C or infection with human immunodeficiency virus (HIV).

        Exclusion Criteria:

          -  men without national health insurance cover

          -  Adults under guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Patricia FAUQUE</last_name>
    <phone>03.80.29.50. 31</phone>
    <phone_ext>+33</phone_ext>
    <email>Patricia.fauque@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia FAUQUE</last_name>
      <phone>03.80.29.50. 31</phone>
      <phone_ext>+33</phone_ext>
      <email>Patricia.fauque@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2016</study_first_submitted>
  <study_first_submitted_qc>August 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2016</study_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

